Report Detail

Pharma & Healthcare Global Rotavirus Vaccines Market Professional Survey Report 2019

  • RnM3806961
  • |
  • 07 October, 2019
  • |
  • Global
  • |
  • 103 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.

The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.

The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.

The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.

The global Rotavirus Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Rotavirus Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rotavirus Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rotavirus Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others

Segment by Application
Adult
Pediatric


Table of Contents

    Executive Summary

      1 Industry Overview of Rotavirus Vaccines

      • 1.1 Definition of Rotavirus Vaccines
      • 1.2 Rotavirus Vaccines Segment by Type
        • 1.2.1 Global Rotavirus Vaccines Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Rotarix
        • 1.2.3 RotaTeq
        • 1.2.4 Rotavac
        • 1.2.5 Rotavin-M1
        • 1.2.6 Lanzhou lamb
        • 1.2.7 Others
      • 1.3 Rotavirus Vaccines Segment by Applications
        • 1.3.1 Global Rotavirus Vaccines Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Adult
        • 1.3.3 Pediatric
      • 1.4 Global Rotavirus Vaccines Overall Market
        • 1.4.1 Global Rotavirus Vaccines Revenue (2014-2025)
        • 1.4.2 Global Rotavirus Vaccines Production (2014-2025)
        • 1.4.3 North America Rotavirus Vaccines Status and Prospect (2014-2025)
        • 1.4.4 Europe Rotavirus Vaccines Status and Prospect (2014-2025)
        • 1.4.5 China Rotavirus Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Japan Rotavirus Vaccines Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Rotavirus Vaccines Status and Prospect (2014-2025)
        • 1.4.8 India Rotavirus Vaccines Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccines
      • 2.3 Manufacturing Process Analysis of Rotavirus Vaccines
      • 2.4 Industry Chain Structure of Rotavirus Vaccines

      3 Development and Manufacturing Plants Analysis of Rotavirus Vaccines

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Rotavirus Vaccines Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Rotavirus Vaccines
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Rotavirus Vaccines Production and Capacity Analysis
      • 4.2 Rotavirus Vaccines Revenue Analysis
      • 4.3 Rotavirus Vaccines Price Analysis
      • 4.4 Market Concentration Degree

      5 Rotavirus Vaccines Regional Market Analysis

      • 5.1 Rotavirus Vaccines Production by Regions
        • 5.1.1 Global Rotavirus Vaccines Production by Regions
        • 5.1.2 Global Rotavirus Vaccines Revenue by Regions
      • 5.2 Rotavirus Vaccines Consumption by Regions
      • 5.3 North America Rotavirus Vaccines Market Analysis
        • 5.3.1 North America Rotavirus Vaccines Production
        • 5.3.2 North America Rotavirus Vaccines Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Rotavirus Vaccines Import and Export
      • 5.4 Europe Rotavirus Vaccines Market Analysis
        • 5.4.1 Europe Rotavirus Vaccines Production
        • 5.4.2 Europe Rotavirus Vaccines Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Rotavirus Vaccines Import and Export
      • 5.5 China Rotavirus Vaccines Market Analysis
        • 5.5.1 China Rotavirus Vaccines Production
        • 5.5.2 China Rotavirus Vaccines Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Rotavirus Vaccines Import and Export
      • 5.6 Japan Rotavirus Vaccines Market Analysis
        • 5.6.1 Japan Rotavirus Vaccines Production
        • 5.6.2 Japan Rotavirus Vaccines Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Rotavirus Vaccines Import and Export
      • 5.7 Southeast Asia Rotavirus Vaccines Market Analysis
        • 5.7.1 Southeast Asia Rotavirus Vaccines Production
        • 5.7.2 Southeast Asia Rotavirus Vaccines Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Rotavirus Vaccines Import and Export
      • 5.8 India Rotavirus Vaccines Market Analysis
        • 5.8.1 India Rotavirus Vaccines Production
        • 5.8.2 India Rotavirus Vaccines Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Rotavirus Vaccines Import and Export

      6 Rotavirus Vaccines Segment Market Analysis (by Type)

      • 6.1 Global Rotavirus Vaccines Production by Type
      • 6.2 Global Rotavirus Vaccines Revenue by Type
      • 6.3 Rotavirus Vaccines Price by Type

      7 Rotavirus Vaccines Segment Market Analysis (by Application)

      • 7.1 Global Rotavirus Vaccines Consumption by Application
      • 7.2 Global Rotavirus Vaccines Consumption Market Share by Application (2014-2019)

      8 Rotavirus Vaccines Major Manufacturers Analysis

      • 8.1 Bharat Biotech
        • 8.1.1 Bharat Biotech Rotavirus Vaccines Production Sites and Area Served
        • 8.1.2 Bharat Biotech Product Introduction, Application and Specification
        • 8.1.3 Bharat Biotech Rotavirus Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck & Co., Inc
        • 8.2.1 Merck & Co., Inc Rotavirus Vaccines Production Sites and Area Served
        • 8.2.2 Merck & Co., Inc Product Introduction, Application and Specification
        • 8.2.3 Merck & Co., Inc Rotavirus Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GlaxoSmithKline plc
        • 8.3.1 GlaxoSmithKline plc Rotavirus Vaccines Production Sites and Area Served
        • 8.3.2 GlaxoSmithKline plc Product Introduction, Application and Specification
        • 8.3.3 GlaxoSmithKline plc Rotavirus Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Lanzhou Institute of Biological
        • 8.4.1 Lanzhou Institute of Biological Rotavirus Vaccines Production Sites and Area Served
        • 8.4.2 Lanzhou Institute of Biological Product Introduction, Application and Specification
        • 8.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bharat Biotech International Limited
        • 8.5.1 Bharat Biotech International Limited Rotavirus Vaccines Production Sites and Area Served
        • 8.5.2 Bharat Biotech International Limited Product Introduction, Application and Specification
        • 8.5.3 Bharat Biotech International Limited Rotavirus Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served

      9 Development Trend of Analysis of Rotavirus Vaccines Market

      • 9.1 Global Rotavirus Vaccines Market Trend Analysis
        • 9.1.1 Global Rotavirus Vaccines Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Rotavirus Vaccines Regional Market Trend
        • 9.2.1 North America Rotavirus Vaccines Forecast 2019-2025
        • 9.2.2 Europe Rotavirus Vaccines Forecast 2019-2025
        • 9.2.3 China Rotavirus Vaccines Forecast 2019-2025
        • 9.2.4 Japan Rotavirus Vaccines Forecast 2019-2025
        • 9.2.5 Southeast Asia Rotavirus Vaccines Forecast 2019-2025
        • 9.2.6 India Rotavirus Vaccines Forecast 2019-2025
      • 9.3 Rotavirus Vaccines Market Trend (Product Type)
      • 9.4 Rotavirus Vaccines Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Rotavirus Vaccines Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Rotavirus Vaccines. Industry analysis & Market Report on Rotavirus Vaccines is a syndicated market report, published as Global Rotavirus Vaccines Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Rotavirus Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,251.50
        4,877.25
        6,503.00
        545,335.00
        818,002.50
        1,090,670.00
        292,390.00
        438,585.00
        584,780.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report